For information about Africhol's programs and activities, please contact:
Latest News, Outbreak Notifications:
Follow Africhol on Twitter
PaxVax lines up $22 million for late-stage cholera vaccine
San Francisco Business Times (4 Dec 2013)
PaxVax Inc. scored $22 million in Series B financing and converted $35 million in debt as it moves forward with a Phase III trial of its cholera vaccine.
Pharmacy sales may be useful in tracking cholera outbreaks
Healio (18 Nov 2013)
Sales of oral rehydration may be an effective tool for tracking cholera outbreaks in a resource-limited setting, according to study findings...
New Cholera Findings Has Been Reported by Investigators at King Mongkut's University of Technology
HispanicBusiness.com (13 Nov 2013)
This study demonstrated the potential application of antibody-conjugated Rubpy dye-doped silica nanoparticles for immunofluorescence microscopic detection of Vibrio cholerae O1.
Cuba developing two cholera vaccines
Global Times (25 Oct 2013)
Cuban researchers are working on developing two orally-taken cholera vaccines, one of which is in advanced clinical trials, experts said in Havana on Thursday.